An 8-year-old with influenza-like illness presents within 48 hours of symptoms onset. Which statement is correct regarding antiviral treatment?

An 8-year-old with influenza-like illness presents within 48 hours of symptoms onset. Which statement is correct regarding antiviral treatment?

• A. Start oseltamivir within 48 hours for high-risk or moderately severe disease
• B. Antibiotics are first-line therapy for influenza
• C. Delay antiviral therapy until 72 hours after onset
• D. Cough suppressants alone are sufficient treatment

Answer: (A)

Starting antiviral therapy early is the most effective approach for pediatric influenza. Medications like oseltamivir work best when given within 48 hours of symptom onset, especially in children at higher risk for complications or with moderately severe illness. In an 8-year-old who can be treated within this window, initiating oseltamivir is appropriate if there are risk factors or the illness is not mild, as it can shorten symptoms and help prevent progression. Antibiotics are not first-line for influenza because it’s a viral infection unless a bacterial coinfection is suspected. Delaying antiviral therapy until 72 hours misses the optimal window for benefit. Cough suppressants alone address symptoms without treating the viral infection or lowering complication risk.

Starting antiviral therapy early is the most effective approach for pediatric influenza. Medications like oseltamivir work best when given within 48 hours of symptom onset, especially in children at higher risk for complications or with moderately severe illness. In an 8-year-old who can be treated within this window, initiating oseltamivir is appropriate if there are risk factors or the illness is not mild, as it can shorten symptoms and help prevent progression.

Antibiotics are not first-line for influenza because it’s a viral infection unless a bacterial coinfection is suspected. Delaying antiviral therapy until 72 hours misses the optimal window for benefit. Cough suppressants alone address symptoms without treating the viral infection or lowering complication risk.